CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Kyphoplasty
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3 Vertebroplasty
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
CHAPTER 5: VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER
5.1 Overview
5.1.1 Market size and forecast
5.2 Hospitals
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3 Ambulatory Surgical Centers
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
CHAPTER 6: VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by Product
6.2.3 North America Market size and forecast, by End User
6.2.4 North America Market size and forecast, by country
6.2.4.1 U.S.
6.2.4.1.1 Key market trends, growth factors and opportunities
6.2.4.1.2 Market size and forecast, by Product
6.2.4.1.3 Market size and forecast, by End User
6.2.4.2 Canada
6.2.4.2.1 Key market trends, growth factors and opportunities
6.2.4.2.2 Market size and forecast, by Product
6.2.4.2.3 Market size and forecast, by End User
6.2.4.3 Mexico
6.2.4.3.1 Key market trends, growth factors and opportunities
6.2.4.3.2 Market size and forecast, by Product
6.2.4.3.3 Market size and forecast, by End User
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by Product
6.3.3 Europe Market size and forecast, by End User
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Key market trends, growth factors and opportunities
6.3.4.1.2 Market size and forecast, by Product
6.3.4.1.3 Market size and forecast, by End User
6.3.4.2 France
6.3.4.2.1 Key market trends, growth factors and opportunities
6.3.4.2.2 Market size and forecast, by Product
6.3.4.2.3 Market size and forecast, by End User
6.3.4.3 UK
6.3.4.3.1 Key market trends, growth factors and opportunities
6.3.4.3.2 Market size and forecast, by Product
6.3.4.3.3 Market size and forecast, by End User
6.3.4.4 Italy
6.3.4.4.1 Key market trends, growth factors and opportunities
6.3.4.4.2 Market size and forecast, by Product
6.3.4.4.3 Market size and forecast, by End User
6.3.4.5 Spain
6.3.4.5.1 Key market trends, growth factors and opportunities
6.3.4.5.2 Market size and forecast, by Product
6.3.4.5.3 Market size and forecast, by End User
6.3.4.6 Rest of Europe
6.3.4.6.1 Key market trends, growth factors and opportunities
6.3.4.6.2 Market size and forecast, by Product
6.3.4.6.3 Market size and forecast, by End User
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by Product
6.4.3 Asia-Pacific Market size and forecast, by End User
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 Japan
6.4.4.1.1 Key market trends, growth factors and opportunities
6.4.4.1.2 Market size and forecast, by Product
6.4.4.1.3 Market size and forecast, by End User
6.4.4.2 China
6.4.4.2.1 Key market trends, growth factors and opportunities
6.4.4.2.2 Market size and forecast, by Product
6.4.4.2.3 Market size and forecast, by End User
6.4.4.3 India
6.4.4.3.1 Key market trends, growth factors and opportunities
6.4.4.3.2 Market size and forecast, by Product
6.4.4.3.3 Market size and forecast, by End User
6.4.4.4 Australia
6.4.4.4.1 Key market trends, growth factors and opportunities
6.4.4.4.2 Market size and forecast, by Product
6.4.4.4.3 Market size and forecast, by End User
6.4.4.5 South Korea
6.4.4.5.1 Key market trends, growth factors and opportunities
6.4.4.5.2 Market size and forecast, by Product
6.4.4.5.3 Market size and forecast, by End User
6.4.4.6 Rest of Asia-Pacific
6.4.4.6.1 Key market trends, growth factors and opportunities
6.4.4.6.2 Market size and forecast, by Product
6.4.4.6.3 Market size and forecast, by End User
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by Product
6.5.3 LAMEA Market size and forecast, by End User
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Brazil
6.5.4.1.1 Key market trends, growth factors and opportunities
6.5.4.1.2 Market size and forecast, by Product
6.5.4.1.3 Market size and forecast, by End User
6.5.4.2 Saudi Arabia
6.5.4.2.1 Key market trends, growth factors and opportunities
6.5.4.2.2 Market size and forecast, by Product
6.5.4.2.3 Market size and forecast, by End User
6.5.4.3 South Africa
6.5.4.3.1 Key market trends, growth factors and opportunities
6.5.4.3.2 Market size and forecast, by Product
6.5.4.3.3 Market size and forecast, by End User
6.5.4.4 Rest of LAMEA
6.5.4.4.1 Key market trends, growth factors and opportunities
6.5.4.4.2 Market size and forecast, by Product
6.5.4.4.3 Market size and forecast, by End User
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 Johnson and Johnson (DePuy Synthes)
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 Medtronic plc
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 Globus Medical Inc
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments
8.4 Halma plc
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Product portfolio
8.4.5 Business performance
8.4.6 Key strategic moves and developments
8.5 Zavation LLC
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Product portfolio
8.5.5 Business performance
8.5.6 Key strategic moves and developments
8.6 BPB MEDICA – BIOPSYBELL
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Operating business segments
8.6.4 Product portfolio
8.6.5 Business performance
8.6.6 Key strategic moves and developments
8.7 Merit Medical Systems Inc.
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Operating business segments
8.7.4 Product portfolio
8.7.5 Business performance
8.7.6 Key strategic moves and developments
8.8 Seawon Meditech
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Operating business segments
8.8.4 Product portfolio
8.8.5 Business performance
8.8.6 Key strategic moves and developments
8.9 Joimax GmbH
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Operating business segments
8.9.4 Product portfolio
8.9.5 Business performance
8.9.6 Key strategic moves and developments
8.10 Stryker Corporation
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Operating business segments
8.10.4 Product portfolio
8.10.5 Business performance
8.10.6 Key strategic moves and developments
TABLE 1. GLOBAL VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 2. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR KYPHOPLASTY, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 3. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR KYPHOPLASTY, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 4. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR VERTEBROPLASTY, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 5. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR VERTEBROPLASTY, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 6. GLOBAL VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 7. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 8. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 9. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 10. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 11. VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 12. NORTH AMERICA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 13. NORTH AMERICA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 14. NORTH AMERICA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 15. U.S. VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 16. U.S. VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 17. CANADA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 18. CANADA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 19. MEXICO VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 20. MEXICO VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 21. EUROPE VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 22. EUROPE VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 23. EUROPE VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 24. GERMANY VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 25. GERMANY VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 26. FRANCE VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 27. FRANCE VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 28. UK VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 29. UK VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 30. ITALY VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 31. ITALY VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 32. SPAIN VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 33. SPAIN VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 34. REST OF EUROPE VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 35. REST OF EUROPE VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 36. ASIA-PACIFIC VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 37. ASIA-PACIFIC VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 38. ASIA-PACIFIC VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 39. JAPAN VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 40. JAPAN VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 41. CHINA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 42. CHINA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 43. INDIA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 44. INDIA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 45. AUSTRALIA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 46. AUSTRALIA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 47. SOUTH KOREA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 48. SOUTH KOREA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 49. REST OF ASIA-PACIFIC VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 50. REST OF ASIA-PACIFIC VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 51. LAMEA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 52. LAMEA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 53. LAMEA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 54. BRAZIL VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 55. BRAZIL VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 56. SAUDI ARABIA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 57. SAUDI ARABIA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 58. SOUTH AFRICA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 59. SOUTH AFRICA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 60. REST OF LAMEA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
TABLE 61. REST OF LAMEA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 62.JOHNSON AND JOHNSON (DEPUY SYNTHES): COMPANY SNAPSHOT
TABLE 63.JOHNSON AND JOHNSON (DEPUY SYNTHES): OPERATING SEGMENTS
TABLE 64.JOHNSON AND JOHNSON (DEPUY SYNTHES): PRODUCT PORTFOLIO
TABLE 65.JOHNSON AND JOHNSON (DEPUY SYNTHES): NET SALES
TABLE 66.JOHNSON AND JOHNSON (DEPUY SYNTHES): KEY STRATERGIES
TABLE 67.MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 68.MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 69.MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 70.MEDTRONIC PLC: NET SALES
TABLE 71.MEDTRONIC PLC: KEY STRATERGIES
TABLE 72.GLOBUS MEDICAL INC: COMPANY SNAPSHOT
TABLE 73.GLOBUS MEDICAL INC: OPERATING SEGMENTS
TABLE 74.GLOBUS MEDICAL INC: PRODUCT PORTFOLIO
TABLE 75.GLOBUS MEDICAL INC: NET SALES
TABLE 76.GLOBUS MEDICAL INC: KEY STRATERGIES
TABLE 77.HALMA PLC: COMPANY SNAPSHOT
TABLE 78.HALMA PLC: OPERATING SEGMENTS
TABLE 79.HALMA PLC: PRODUCT PORTFOLIO
TABLE 80.HALMA PLC: NET SALES
TABLE 81.HALMA PLC: KEY STRATERGIES
TABLE 82.ZAVATION LLC: COMPANY SNAPSHOT
TABLE 83.ZAVATION LLC: OPERATING SEGMENTS
TABLE 84.ZAVATION LLC: PRODUCT PORTFOLIO
TABLE 85.ZAVATION LLC: NET SALES
TABLE 86.ZAVATION LLC: KEY STRATERGIES
TABLE 87.BPB MEDICA – BIOPSYBELL: COMPANY SNAPSHOT
TABLE 88.BPB MEDICA – BIOPSYBELL: OPERATING SEGMENTS
TABLE 89.BPB MEDICA – BIOPSYBELL: PRODUCT PORTFOLIO
TABLE 90.BPB MEDICA – BIOPSYBELL: NET SALES
TABLE 91.BPB MEDICA – BIOPSYBELL: KEY STRATERGIES
TABLE 92.MERIT MEDICAL SYSTEMS INC.: COMPANY SNAPSHOT
TABLE 93.MERIT MEDICAL SYSTEMS INC.: OPERATING SEGMENTS
TABLE 94.MERIT MEDICAL SYSTEMS INC.: PRODUCT PORTFOLIO
TABLE 95.MERIT MEDICAL SYSTEMS INC.: NET SALES
TABLE 96.MERIT MEDICAL SYSTEMS INC.: KEY STRATERGIES
TABLE 97.SEAWON MEDITECH: COMPANY SNAPSHOT
TABLE 98.SEAWON MEDITECH: OPERATING SEGMENTS
TABLE 99.SEAWON MEDITECH: PRODUCT PORTFOLIO
TABLE 100.SEAWON MEDITECH: NET SALES
TABLE 101.SEAWON MEDITECH: KEY STRATERGIES
TABLE 102.JOIMAX GMBH: COMPANY SNAPSHOT
TABLE 103.JOIMAX GMBH: OPERATING SEGMENTS
TABLE 104.JOIMAX GMBH: PRODUCT PORTFOLIO
TABLE 105.JOIMAX GMBH: NET SALES
TABLE 106.JOIMAX GMBH: KEY STRATERGIES
TABLE 107.STRYKER CORPORATION: COMPANY SNAPSHOT
TABLE 108.STRYKER CORPORATION: OPERATING SEGMENTS
TABLE 109.STRYKER CORPORATION: PRODUCT PORTFOLIO
TABLE 110.STRYKER CORPORATION: NET SALES
TABLE 111.STRYKER CORPORATION: KEY STRATERGIES
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
